Prem Soman

7PUBLICATIONS
55CO-AUTHORS
Autonomic nervous systemMedical biotechnology diagnostics (incl. biosensors)Astronomical instrumentationGene and molecular therapyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 31, 2026
Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial.

|Nov 26, 2025
Changing Patterns of Diagnosis and Survival in Transthyretin Cardiac Amyloidosis: A Multicenter Cohort Study.

Brett W Sperry, Ahmad Masri, Prem Soman

|Nov 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial.

Daniel P Judge, Julian D Gillmore, Kevin M Alexander

|Jun 04, 2024
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.

Mathew S Maurer, Prem Soman, Adrian Hernandez

|Jul 14, 2023
Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis.

Hassan A Alhassan, Aleesha Kainat, Joseph Donohue

Pageof 2

Frequent Collaborators

3 joint publications

Ahmad Masri

3 joint publications

Mathew S Maurer

3 joint publications

Julian Gillmore

2 joint publications

Jonathan C Fox